Vycor Medical (VYCO) Retained Earnings (2010 - 2026)

Vycor Medical (VYCO) has reported Retained Earnings for 17 consecutive years, with -$33.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings fell 1.15% year-over-year to -$33.8 million in Q2 2026; TTM through Jun 2026 was -$33.8 million, a 1.15% decrease from a year earlier, with the FY2025 full-year figure at -$33.6 million, down 1.19% from the prior year.
• Retained Earnings was -$33.8 million for Q2 2026 at Vycor Medical, roughly flat from -$33.8 million in the prior quarter.
• Over five years, Retained Earnings peaked at -$31.9 million in Q1 2022 and troughed at -$33.8 million in Q2 2026.
• A 5-year average of -$33.0 million and a median of -$33.0 million in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings dropped 2.54% in 2022 and fell 1.01% in 2026, its largest moves.
• Over 5 years, Retained Earnings stood at -$32.4 million in 2022, then dropped by 1.22% to -$32.8 million in 2023, then slipped by 1.31% to -$33.3 million in 2024, then decreased by 1.19% to -$33.6 million in 2025, then slipped by 0.49% to -$33.8 million in 2026.
• The last three Retained Earnings figures came in at -$33.8 million (Q2 2026), -$33.8 million (Q1 2026), and -$33.6 million (Q4 2025), per Business Quant data.